Literature DB >> 15844828

Hawthorn: potential roles in cardiovascular disease.

Wei-Tien Chang1, Jenny Dao, Zuo-Hui Shao.   

Abstract

Hawthorn (Crataegus) may play a role in the prevention and treatment of cardiovascular diseases such as hypertension, hyperlipidemia, and in particular, congestive heart failure. Evidence is accumulating that hawthorn may induce anti-ischemia/reperfusion-injury, anti-arrhythmic, hypolipidemic and hypotensive effects. These beneficial effects may in part be due to the presence of antioxidant flavonoid components. While a number of studies have been performed to evaluate the clinical efficacy of hawthorn, an international, multicenter, prospective clinical study including a large number of New York Heart Association (NYHA) class II/III heart failure patients is ongoing to test hawthorn's long-term therapeutic effects. Further clinical trials as well as pharmacokinetic and mechanistic studies are needed to explore and confirm its effectiveness, safety and pharmacological mechanism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15844828     DOI: 10.1142/S0192415X05002606

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  32 in total

1.  Hawthorn (Crataegus monogyna Jacq.) extract exhibits atropine-sensitive activity in a cultured cardiomyocyte assay.

Authors:  Satin Salehi; Shannon R Long; Philip J Proteau; Theresa M Filtz
Journal:  J Nat Med       Date:  2008-08-12       Impact factor: 2.343

2.  The new LOCI digoxin assay on the Vista 1500 analyzer is virtually free from interferences of herbal supplements hawthorn and ashwagandha (Indian ginseng).

Authors:  Amitava Dasgupta; Myrtle J Johnson; Amer Wahed
Journal:  J Clin Lab Anal       Date:  2012-07       Impact factor: 2.352

3.  The Association Between Complementary and Alternative Medicine and Health Status Following Acute Myocardial Infarction.

Authors:  Ali Shafiq; Natalie Jayaram; Kensey L Gosch; John A Spertus; Donna M Buchanan; Carole Decker; Mikhail Kosiborod; Suzanne V Arnold
Journal:  Clin Cardiol       Date:  2016-05-31       Impact factor: 2.882

4.  Blood Pressure Change After Celery Juice Ingestion in a Hypertensive Elderly Male.

Authors:  Jennifer D Illes
Journal:  J Chiropr Med       Date:  2021-06-16

5.  American ginseng berry juice intake reduces blood glucose and body weight in ob/ob mice.

Authors:  J T Xie; C Z Wang; M Ni; J A Wu; S R Mehendale; H H Aung; A Foo; C S Yuan
Journal:  J Food Sci       Date:  2007-10       Impact factor: 3.167

6.  Hawthorn leaves flavonoids decreases inflammation related to acute myocardial ischemia/reperfusion in anesthetized dogs.

Authors:  Jian-Hua Fu; Yong-Qiu Zheng; Peng Li; Xin-Zhi Li; Xiao-Hong Shang; Jian-Xun Liu
Journal:  Chin J Integr Med       Date:  2012-12-03       Impact factor: 1.978

Review 7.  Commonly used antioxidant botanicals: active constituents and their potential role in cardiovascular illness.

Authors:  Chong-Zhi Wang; Sangeeta R Mehendale; Chun-Su Yuan
Journal:  Am J Chin Med       Date:  2007       Impact factor: 4.667

8.  Antihypertensive effect of celery seed on rat blood pressure in chronic administration.

Authors:  Maryam Hassanpour Moghadam; Mohsen Imenshahidi; Seyed Ahmad Mohajeri
Journal:  J Med Food       Date:  2013-06-04       Impact factor: 2.786

9.  Ethanol extract of Zhongtian hawthorn lowers serum cholesterol in mice by inhibiting transcription of 3-hydroxy-3-methylglutaryl-CoA reductase via nuclear factor-kappa B signal pathway.

Authors:  Hai-Jie Hu; Xue-Gang Luo; Qing-Qing Dong; Ai Mu; Guo-Long Shi; Qiu-Tong Wang; Xiao-Ying Chen; Hao Zhou; Tong-Cun Zhang; Li-Wen Pan
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-28

10.  Evaluation of prescribing patterns in a German network of CAM physicians for the treatment of patients with hypertension: a prospective observational study.

Authors:  Elke Jeschke; Thomas Ostermann; Horst C Vollmar; Matthias Kröz; Angelina Bockelbrink; Claudia M Witt; Stefan N Willich; Harald Matthes
Journal:  BMC Fam Pract       Date:  2009-12-10       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.